Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Neoplasms 44Breast Neoplasms 42Lung Neoplasms 27Carcinoma, Non-Small-Cell Lung 21Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Ovarian Neoplasms 11Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Pancreatic Neoplasms 10Melanoma 10Brain Neoplasms 9Sarcoma 7Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Multiple Myeloma 6Gastrointestinal Neoplasms 6Disease 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

Curcumin 3piperine 1Urination 1Tissue Banks 1Probiotics 1Metformin 1Docosahexaenoic Acids 1Diet, Plant-Based 1Diet, Mediterranean 1Blood Specimen Collection 1Biopsy 1Absorptiometry, Photon 14-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Monoclonal Gammopathy of Undetermined Significance × Blood Specimen Collection × 1 year × Clear all
NCT06644625 2026-01-20

CHAAMP (CHArlotte Advocate MGUS Project) Internal Pilot Study

Wake Forest University Health Sciences

Recruiting
1,665 enrolled
Plasma cell

Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡